Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q4 2022 Earnings

31MarExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-15
-10.07
-5.14
-0.21

Details

Expected EPS
-0.21
Actual EPS
-12.98
Surprise EPS
-12.77
Surprise Percent
+6,080.95%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -12.98 per share for Q4 2022.

0 Comments

Share your thoughts